Use of allogenic, homozygous bone marrow cells for the induction of specific immunologic tolerance in mice treated with antilymphocyte serum.
D000818:Animals; D000941:Antigens / Q000008:administration & dosage; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D001853:Bone Marrow / Q000276:immunology*; D001854:Bone Marrow Cells; D006084:Graft Rejection; D007108:Immune Tolerance; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008214:Lymphocytes / Q000276:immunology; D051379:Mice; D011817:Rabbits; D016038:Skin Transplantation; D013154:Spleen / Q000276:immunology; D013950:Thymus Gland / Q000276:immunology; D013997:Time Factors; D014022:Tissue Survival; D014184:Transplantation, Homologous
D000941:Antigens; D000961:Antilymphocyte Serum